Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

506
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
506
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

336
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
336
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

389
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
389
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

417
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
417
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

850
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
850

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertrophic Obstructive Cardiomyopathy.

Deutsches Arzteblatt international·2019
Same author

Surgery of Hypertrophic Obstructive Cardiomyopathy in Patients With Severe Hypertrophy, Myocardial Fibrosis, and Ventricular Tachycardia.

The Annals of thoracic surgery·2018
Same author

Surgical treatment of hypertrophic obstructive cardiomyopathy in pediatric patients with severe hypertrophy.

Artificial organs·2008
Same journal

Endoscopic removal of a papillary fibroelastoma of the tricuspid valve.

Annals of cardiothoracic surgery·2026
Same journal

Tricuspid valve repair in infective endocarditis.

Annals of cardiothoracic surgery·2026
Same journal

The pitfalls of transcatheter tricuspid valve repair: what we have learned in our last decade of experience.

Annals of cardiothoracic surgery·2026
Same journal

The value of preoperative risk scores prior to tricuspid valve interventions: The TRI-SCORE and beyond.

Annals of cardiothoracic surgery·2026
Same journal

Three decades evolution of the lifetime management approach to tricuspid valve disease: a multidisciplinary European perspective from a high-volume heart valve center.

Annals of cardiothoracic surgery·2026
Same journal

Innovations in transcatheter tricuspid valve interventions: what has failed, what has worked, what is coming.

Annals of cardiothoracic surgery·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.1K

Right ventricle myectomy.

Konstantin V Borisov1,2

  • 1University Paris Descartes, Sorbonne Paris Cite, 75475 Paris, France.

Annals of Cardiothoracic Surgery
|September 26, 2017
PubMed
Summary
This summary is machine-generated.

A novel right ventricular (RV) myectomy technique effectively treats severe hypertrophic obstructive cardiomyopathy (HCM) with biventricular obstruction. This approach offers a safer alternative for high-risk patients, improving outcomes in complex HCM cases.

Keywords:
Hypertrophic obstructive cardiomyopathybiventricular obstructionmyectomyright ventricular hypertrophy

More Related Videos

Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
06:04

Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model

Published on: June 9, 2023

1.6K
Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

3.5K

Related Experiment Videos

Last Updated: Feb 22, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.1K
Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
06:04

Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model

Published on: June 9, 2023

1.6K
Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

3.5K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardiovascular Disease

Background:

  • Right ventricular (RV) hypertrophy is prevalent in hypertrophic cardiomyopathy (HCM) and indicates severe disease.
  • Conventional surgical methods like the Morrow procedure carry high risks for patients with severe RV hypertrophy and obstruction.
  • Optimal therapeutic strategies for severe HCM with biventricular obstruction remain undefined.

Purpose of the Study:

  • To introduce and evaluate a novel surgical technique for RV myectomy in patients with hypertrophic obstructive cardiomyopathy (HCM) and severe hypertrophy.
  • To analyze the indications and techniques for RV myectomy in managing biventricular obstruction.
  • To present follow-up results for patients undergoing RV myectomy for severe HCM.

Main Methods:

  • A new surgical approach involving entry through the conal part of the RV to access and remove obstructive septal fibrotic tissue.
  • Literature review of current RV myectomy techniques and indications.
  • Analysis of follow-up data for patients with biventricular obstruction and severe HCM.

Main Results:

  • The novel RV approach effectively eliminates biventricular obstruction.
  • Precise removal of septal fibrotic areas was achieved in patients with hypertrophic obstructive cardiomyopathy.
  • The technique demonstrated feasibility and efficacy in managing complex HCM cases.

Conclusions:

  • The proposed RV myectomy technique offers an effective solution for severe hypertrophic obstructive cardiomyopathy with biventricular obstruction.
  • This novel approach may provide a safer and more precise surgical option for high-risk HCM patients.
  • Further studies and long-term follow-up are warranted to solidify the role of this technique in HCM management.